Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000950170-24-132930

Chief Executive Officer sold 48,847 shares at $4.56 ($222,527)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tak Paul Peter Chief Executive Officer 2024-11-29 Sale −48,847 $4.56 $222,527 294,788 D
Open-market sales · 48,847 sh · avg $4.56 · $222,527
Loading xslF345X05/ownership.xml…